- Email: [email protected]
Extracellular matrix and wound healing
G Model
PATBIO-3107; No. of Pages 5 Pathologie Biologie xxx (2014) xxx–xxx
Available online at
ScienceDirect www.sciencedirect.com
60th anniversary
Extracellular matrix and wound healing Matrice extracellulaire et cicatrisation F.X. Maquart a,*,b, J.C. Monboisse a,b a b
Laboratoire de biochimie et biologie mole´culaire, CNRS FRE 3481, faculte´ de me´decine, 51, rue Cognacq-Jay, CS 30018, 51095 Reims, France Laboratoire central de biochimie, CHU de Reims, rue Serge-Kochman, 51092 Reims, France
A R T I C L E I N F O
A B S T R A C T
Article history: Received 13 December 2013 Accepted 17 February 2014 Available online xxx
Extracellular matrix has been known for a long time as an architectural support for the tissues. Many recent data, however, have shown that extracellular matrix macromolecules (collagens, elastin, glycosaminoglycans, proteoglycans and connective tissue glycoproteins) are able to regulate many important cell functions, such as proliferation, migration, protein synthesis or degradation, apoptosis, etc., making them able to play an important role in the wound repair process. Not only the intact macromolecules but some of their specific domains, that we called ‘‘Matrikines’’, are also able to regulate many cell activities. In this article, we will summarize main findings showing the effects of extracellular matrix macromolecules and matrikines on connective tissue and epithelial cells, particularly in skin, and their potential implication in the wound healing process. These examples show that extracellular matrix macromolecules or some of their specific domains may play a major role in wound healing. Better knowledge of these interactions may suggest new therapeutic targets in wound healing defects. ß 2014 Elsevier Masson SAS. All rights reserved.
Keywords: Extracellular matrix Wound healing Collagen Elastin Glycosaminoglycans Proteoglycans Connective tissue glycoproteins Matrikines
R E´ S U M E´
Mots cle´s : Matrice extracellulaire Cicatrisation Collage`ne E´lastine Glycosaminoglycannes Prote´oglycannes Glycoprote´ines du tissu conjonctif Matrikines
La matrice extracellulaire est connue de longue date comme support architectural pour les tissus. De nombreux re´sultats re´cents indiquent, cependant, que les macromole´cules matricielles (collage`ne, e´lastine, glycosaminoglycannes, prote´oglycannes et glycoprote´ines du tissu conjonctif) sont capables de re´guler de nombreuses fonctions cellulaires telles que la prolife´ration, la migration, la synthe`se ou la de´gradation des prote´ines, l’apoptose, etc., les rendant capables de jouer un roˆle important dans le processus de cicatrisation. Non seulement les mole´cules intactes, mais aussi certains de leurs domaines spe´cifiques, que nous avons appele´s « Matrikines », sont capables de re´guler de nombreuses activite´s cellulaires. Dans cet article, nous re´sumerons les principales de´couvertes montrant les effets des macromole´cules matricielles et des matrikines sur les cellules des tissus conjonctifs et les cellules e´pithe´liales, en particulier dans la peau, et leur implication potentielle dans le processus de cicatrisation. Ces exemples montrent que les macromole´cules de la matrice extracellulaire ou certains de leurs domaines spe´cifiques peuvent jouer un roˆle majeur dans la cicatrisation. Une meilleure connaissance de ces interactions peut sugge´rer de nouvelles cibles the´rapeutiques dans les de´ficits de cicatrisation. ß 2014 Elsevier Masson SAS. Tous droits re´serve´s.
1. Introduction Wound healing is a very complex process, associating cellular, molecular, biochemical and physiological events, which permit living organisms to repair accidental lesions. It necessitates the
* Corresponding author. E-mail address: [email protected] (F.X. Maquart).
coordinated intervention of many partners, among which blood cells, epithelial and connective tissue cells, inflammatory cells and many soluble factors, mainly coagulation factors, growth factors and cytokines. It is a dynamic and strongly regulated process implicating molecular, cellular and humoral components, which starts immediately after the initial lesion and will last until complete closure of the wound and restitution of a tissue as functional as possible. In the case of fetal wound, complete
http://dx.doi.org/10.1016/j.patbio.2014.02.007 0369-8114/ß 2014 Elsevier Masson SAS. All rights reserved.
Please cite this article in press as: Maquart FX, Monboisse JC. Extracellular matrix and wound healing. Pathol Biol (Paris) (2014), http:// dx.doi.org/10.1016/j.patbio.2014.02.007
G Model
PATBIO-3107; No. of Pages 5 2
F.X. Maquart, J.C. Monboisse / Pathologie Biologie xxx (2014) xxx–xxx
regeneration of the initial tissue may occur whereas in adults, the wound healing process conducts in most case to the formation of a collagenic scar [1]. Among the factors implicated in the control of the wound healing process, an important partner is the extracellular matrix. It is now well admitted that extracellular matrix is not only an architectural support for the tissues but also plays a major role in cell regulation. Presently, many data show that nearly all the extracellular matrix components are able to regulate cell behaviour. It is clear that the important extracellular matrix alterations that occur during wound healing make it a very important player in this process. This review will summarize main findings showing the effects of extracellular matrix macromolecules on the cells implicated in the wound healing process. A better understanding of the mechanisms involved in these cell-extracellular matrix interactions may suggest new targets for therapeutic strategies in the management of the wound healing defects. 2. The fibrin clot: a provisional matrix As pointed out by Richard Clark many years ago, the fibrin clot by itself constitutes a provisional extracellular matrix, composed of 95% fibrin and many other components, mainly fibronectin, SPARC/osteonectin, thrombospondin and vitronectin. These components may support cell migration necessary for wound healing, but also trigger the inflammation process. For instance, fibrin itself induces the secretion of IL-8 by endothelial cells and of TNFa, IL1ß, IL-6, MIP-1, MIP-2 and MCP-1 by mononuclear cells [2]. Fibrin is rapidly degraded by plasmin and neutrophil elastase. This degradation may induce the release of plasma growth factors trapped in the fibrin lattice, which might play an important role in the early events of wound healing. Fibrin also releases fibrin degradation products, most of which may stimulate the healing process. Fibrin degradation products can induce or amplify the inflammatory process. For instance, fibrinopeptides A and B are chemo-attractant for neutrophils, monocytes and macrophages; D-dimers induce secretion of IL-1ß and IL-6 by mononuclear cells; fragment E induces secretion of IL-1ß and IL-6 by mononuclear cells; fragment ß15-42 is chemo-attractant for neutrophils and fibroblasts (for review, see ref [3]). Fibrin degradation products were also shown to stimulate extracellular matrix deposition [4], fibroblast proliferation [5] and angiogenesis [6]. 3. Extracellular matrix macromolecules as modulators of cell functions in wound healing Extracellular matrix (ECM) is made of collagen and elastic fibers dispersed in a ground substance made of glycosaminoglycans, proteoglycans and connective tissue glycoproteins. Many data have shown that ECM is able to modulate wound repair, either directly by modulating important aspects of cell behaviour such as adhesion, migration, proliferation or survival, or indirectly by modulating extracellular protease secretion, activation and activity, or modulating growth factor activity or bioavailability. Actually, sequestration/release of growth factors by the ECM may prolongate growth factor action or modulate their activity on the cells implicated in the wound healing process. 3.1. Glycosaminoglycans Glycosaminoglycan chains are very important players in wound healing. The most important is hyaluronic acid, a non-sulfated glycosaminoglycan, very abundant in skin [7] where it forms long filaments (500 nm–10 mm) and provides to the tissue its visco-
elasticity and hydrophilicity. Hyaluronic acid, also called hyaluronan, interacts with cell surface receptors, mainly CD-44 and RHAMM (Receptor for HyaluronAn Mediated Mobility), but also Toll-like Receptors TLR-4 and TLR-2, and Inter Cellular Adhesion Molecule-1 (ICAM-1). The interaction of hyaluronan with its receptor induces very important events in the wound repair process: modulation of inflammation, chemotaxis, cell migration, collagen secretion and angiogenesis [8–10]. The abundance of hyaluronan in fetal skin is likely one of the factors which permits to the early gestation fetal skin wound to heal without scar formation [11]. Similarly, the over-expression of hyaluronan synthase-1 is able to induce regenerative wound repair in C57Bl/6 mice [12]. Many data demonstrated that the biological effects of hyaluronan are dependent of its molecular size. For instance, recent data from Ghazi et al. [13] showed that hyaluronan with a molecular weight comprised between 100–300 kDa was able to strongly stimulate keratinocyte migration whereas high molecular weight (1000– 1400 kDa) and low molecular weight (5–20 kDa) hyaluronan fragments had no effect. Earlier, David Raoudi et al. [14] demonstrated that native hyaluronan of high molecular weight (1.7 MDa) stimulated type III collagen production whereas low molecular weight hyaluronan fragments (12 disaccharide units) stimulated type I collagen production by human dermal fibroblasts. Low molecular weight fragments of hyaluronan (10 saccharide units) were also shown to stimulate angiogenesis in rat experimental wounds [15]. Sulfated glycosaminoglycans (chondroitin-sulfate, dermatansulfate, keratan-sulfate and heparan-sulfate) are linked to core proteins to form proteoglycans in normal tissues, especially in skin. Proteoglycan degradation by proteases in the wounds may, however, lead to the release of free glycosaminoglycan chains, which may modulate the wound healing process [16]. For instance, chondroitin-sulfate and dermatan-sulfate regulate growth factor activity and may stimulate nitric oxide production which, in turn, can modulate angiogenesis. Heparan-sulfate stimulates the release of IL-1, IL-6, PGE2 and TGF-ß, inhibits elastase and cathepsin-G activity, complexes chemokines, cytokines and growth factors. It is also well known to stabilize tetrameric complexes between FGF2 or other heparin-binding growth factors and their receptors, improving signal transduction [17]. Heparan sulfate chains may also bind VEGF and contribute to the modulation of its proangiogenic effects in the tissues [18]. 3.2. Proteoglycans Many proteoglycans are involved in the wound healing process. Main skin proteoglycans are small leucine-rich proteoglycans (SLRPs) family and versican, essentially present in the dermis, perlecan in the basement membrane, syndecans and glypicans on the cell surface. Decorin, the first known member of the SLRP family, was shown many years ago to negatively regulate TGF-ß [19]. Delayed wound healing was observed in perlecan-deficient mice, due to an impaired angiogenesis [20]. The V3 isoform of versican was shown to stimulate elastin production [21], to promote angiogenesis [22], and to induce transition of normal dermal fibroblasts to myofibroblasts [23]. Syndecans 1 and 4 are strongly expressed in wounds [24]. Their increased expression stimulate keratinocyte and endothelial cell migration whereas invalidation of the syndecan-4 chain delays wound closure and angiogenesis in mice [25,26]. Threedimensional migration of fibroblasts into fibrin is also decreased when syndecan-4 core protein synthesis is suppressed by anti-sense oligodeoxynucleotides [27]. 3.3. Connective tissue glycoproteins Connective tissue glycoproteins are a group of extracellular matrix macromolecules strongly involved in cell regulation and
Please cite this article in press as: Maquart FX, Monboisse JC. Extracellular matrix and wound healing. Pathol Biol (Paris) (2014), http:// dx.doi.org/10.1016/j.patbio.2014.02.007
G Model
PATBIO-3107; No. of Pages 5 F.X. Maquart, J.C. Monboisse / Pathologie Biologie xxx (2014) xxx–xxx
3
many of them may be involved in the wound healing process, either directly or indirectly. Thrombospondin-1, for instance, is well known for activating latent TGF-ß which [28] in turn, may activate fibroblasts to produce extracellular matrix. Tenascin-C, a matricellular protein transiently expressed during wound healing, was shown to stimulate macrophage and fibroblast activation [29]. It is also a potent stimulator of angiogenesis [30] and is able to protect multipotential mesenchymal stem cells from death cytokines [31]. Fibronectin also plays a crucial role in wound healing by promoting keratinocyte and fibroblast migration, wound contraction, and stabilization of the newly synthetized collagen matrix [32].
[49]. Elastokines interact with their target cells through a specific receptor complex composed of a spliced variant of ß-galactosidase (S-Gal) associated at the cell plasma membrane with neuraminidase-1 (Neu-1) and to cathepsin-A (Cath-A) [50], which binds the consensus sequence GXXPG, a peptide sequence with a type VIII ßturn conformation frequently found in elastin [51]. Laminin 3.3.2 (laminin-5) isoform present in the dermoepidermal junction also contains some domains, especially the LG3 domain of the a3 chain, which stimulate keratinocyte migration and proliferation [52,53]. The many EGF-like domains contained in the tenascin-C amino-acid sequence may also be released by proteases and interact with EGF receptor to stimulate fibroblast proliferation and migration [54].
4. Matrikines in wound healing
5. Small collagen-derived peptides and hypoxia in wound healing
Matrikines are specific domains of extracellular matrix macromolecules, released by partial proteolysis, which are able to modulate many cell activities [33]. Many published data indicate that they may play a major role in the control of wound repair. Matrikines may be produced during proteolytic degradation of extracellular matrix, a process necessary for wound healing. For instance, it was demonstrated that wound healing is severely affected in collagenase-deficient and in plasminogen/plasmindeficient mice [34,35]. The capacity of extracellular matrix macromolecules to exert biological activities on connective tissue cells was demonstrated that a fragment of connective tissue glycoproteins extracted from rabbit dermis was able to inhibit fibroblast proliferation [36]. On the other hand, Laskin et al. [37] demonstrated that collagenderived peptides containing 3 or 5 repeats of the Pro-Hyp-Gly tripeptide were able to exert chemotactic effects on polymorphonuclear neutrophils. One of the best characterized matrikines involved in wound repair is the tripeptide glycyl-histidyl-lysine (GHK) present in many extracellular matrix proteins such as the collagen a2(I), a2(V) and a2(IX) chains, the SPARC glycoprotein, thrombospondin-1, and fibrin a-chain [38]. The peptide may be released from the extracellular matrix proteins by proteases to exert biological effects. It is present in biological fluids under the form of a free or complexed with Cu2+ ions tripeptide [39]. Many data from our laboratory and others demonstrated that GHK has many biological effects in wound healing, such as stimulation of collagen, glycosaminoglycan and proteoglycan synthesis [40] and acceleration of wound healing in vivo [41]. Interestingly, recent data by Choi et al. [42] showed a stem cell recovering effect of copper-free GHK in skin, suggesting a modulating effect of this peptide on stem cell renewal. GHK and GHK-Cu complexes are now found in a lot of cosmetic products for skin repair. They are not, however, the only collagen-derived matrikine since two others, KTTKS (lysylthreonyl-threonyl-lysyl-serine), a penta-peptide derived from the carboxyl-terminal propeptide of type I collagen [43], and GEKG (glycyl-glutamyl-lysyl-glycine), a tetrapeptide derived from the type I collagen triple helical domain [44], were shown to stimulate extracellular matrix macromolecule production. Part of these effects are mediated by an up-regulation of TGFß [45]. Elastin degradation is also an important source of matrikines in pathological tissues. A biological activity of elastin-derived peptides, also called ‘‘elastokines’’ [46], was first demonstrated for kappa-elastin, a mixture of elastin fragments obtained by alkaline hydrolysis of elastic fibers [47], which was shown to modulate ion fluxes in mononuclear cells [48]. Elastokines are able to stimulate many events in the wound healing process: monocytes and polymorphonuclear neutrophil activation, leukocyte migration, chemotaxis, keratinocyte migration, fibroblast proliferation, vasodilatation, angiogenesis, and matrix remodeling
Matrikines are not the only peptides derived from extracellular matrix degradation. Actually, a large amount of proline and hydroxyproline-containing peptides are also released. Among them, Gly-Pro and Gly-Hyp dipeptides stimulate activity of prolidase (EC3.4.13.9), an enzyme which specifically releases proline and hydroxyproline from iminodipeptides [55]. Previous studies of Surazynski et al. [56] demonstrated that overexpression of prolidase resulted in increased hypoxia inducible factor-1a (HIF-1a). This effect was due both to an activation of the hypoxia response element (HRE) by prolidase, resulting in an increased transcription of the HIF-1a gene, and to an inhibition of HIF-1a degradation. Increased levels and increased stability of HIF-1a are responsible for VEGF gene activation which, in turn, activates angiogenesis and improves wound healing [57,58]. 6. The role of integrins in wound healing Integrins are very important partners in wound healing. They mediate attachment of cells to the extracellular matrix. They are also involved in the regulation of cell behaviour and play a major role in cell-extracellular matrix interactions [59]. In the case of wound healing, it was shown that b1-integrin is necessary for keratinocyte migration in vivo and in experimental wounds [60]. Similarly, it was demonstrated that the a3 subunit of a3b1 integrin was able to regulate reepithelialisation during wound healing through SMAD-7 activation [61]. Integrins are also involved in neo-angiogenesis, a very important process in wound healing. Blocking a1 and a2 integrins by specific antibodies suppressed the stimulation of neo-capillary formation by VEGF in dermal microvascular endothelial cells [62]. Similarly, blocking avb3 integrin expression in wound granulation tissue suppressed neo-angiogenesis induced by FGF-2 and TNF-a [63]. 7. Conclusion Intact or partially degraded extracellular matrix macromolecules may play a major role on the activity of the cells implicated in the wound healing process. They may act either directly by interacting with specific receptors of the cell surface membrane such as integrins, CD-44, the elastin receptor complex or others, or indirectly by modulating the activity, activation or bio-availability of many cytokines and growth factors. Every cell type involved in wound healing, inflammatory cells, keratinocytes, fibroblasts, endothelial cells or pluripotent stem cells are concerned by these interactions with extracellular matrix macromolecules or their fragments. Such interactions may constitute new target for the wound healing defects.
Please cite this article in press as: Maquart FX, Monboisse JC. Extracellular matrix and wound healing. Pathol Biol (Paris) (2014), http:// dx.doi.org/10.1016/j.patbio.2014.02.007
G Model
PATBIO-3107; No. of Pages 5 F.X. Maquart, J.C. Monboisse / Pathologie Biologie xxx (2014) xxx–xxx
4
Acknowledgements Author’s works are supported by the university of ReimsChampagne-Ardenne, CNRS, region Champagne-Ardenne, FEDER and the Ligue nationale contre le cancer. Mrs Pascale Hennequin and Sandrine E´tienne are greatly acknowledged for careful typing of the manuscript. References [1] Reinkes JM, Sorg H. Wound repair and regeneration. Eur Surg Res 2012;49: 35–43. [2] Clark RA, Lanigan JM, Della Pelle P, Mansean E, Dvorak HF, Colvin RB. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 1982;9:269–76. [3] Jennewein C, Tran N, Paulus P, Ellinghans P, Eble JA, Zacharowski K. Novel aspects of fibrin(ogen) fragments during inflammation. Mol Med 2011;17: 568–73. [4] Ahmann KA, Weinbaum JS, Johnson SL, Tranquillo RT. Fibrin degradation products enhance vascular smooth muscle cell proliferation and matrix deposition in fibrin-based tissue constructs fabricated in vitro. Tissue Engin Part A 2010;16:3261–70. [5] Gray AJ, Bishop JE, Reeves JT, Mecham RP, Laurent GJ. Partially degraded fibrin(ogen) stimulates fibroblast proliferation in vitro. Am J Resp Cell Mol Biol 1995;12:684–90. [6] Dvorak HF, Harvey VS, Estrella P, Brown LF, Mc Donagh J, Dvorak AM. Fibrincontaining gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 1987;57:673–86. [7] Manuskiatti W, Maibach HI. Hyaluronic acid and skin: wound healing and aging. Int J Dermatol 1996;35:539–44. [8] Frenkel JS. The role of hyaluronan in wound healing. Int Wound J 2012 [doc:10.1111/j 1742-481X.2012.01057.x]. [9] Chen WYJ, Abatangelo G. Functions of hyaluronan in wound repair. Wound Rep Reg 1999;7:79–89. [10] Prodicimi M, Bevilacqua C. Exogenous hyaluronic acid and wound healing: an up-dated vision. Panminerva Med 2012;54:129–35. [11] Lo DD, Zimmerman AS, Nauta A, Longaker MT, Lorenz HP. Scarless fetal skin wound healing update. Birth Defects Res C Embryo Today 2012;96:237–47. [12] Caskey RC, Allukian M, Lind RC, Herdrich BJ, Xu J, Radu A, et al. Lentiviralmediated over expression of hyaluronan synthase-1 (HAS-1) decreases the cellular inflammatory response and results in regenerative wound repair. Cell Tissue Res 2013;351:117–25. [13] Ghazi K, Deng-Pichon U, Warnet JM, Rat P. Hyaluronan fragments improve wound healing on in vitro cutaneous model through P2X7 purinoreceptor basal activation: role of molecular weight. PLoS ONE 2012;7:e48351. [14] David-Raoudi M, Tranchepain F, Deschevrel B, Vincent JC, Bogdanowicz P, Boumediene K, et al. Differential effects of hyaluronan and its fragments on fibroblasts: relation to wound healing. Wound Rep Reg 2008;16:274–87. [15] Gao F, Liu Y, Yang C, Wang Y, Shi X, Wei G. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis. Matrix Biol 2010;29:107–16. [16] Peplow PV. Glycosaminoglycan: a candidate to stimulate the repair of chronic wounds. Thromb Haemostas 2005;94:4–16. [17] Taylor KR, Gallo RL. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J 2006;20:9–22. [18] Ortega N, L’Faquihi FE, Ploue¨t J. Control of vascular endothelial growth factor angiogenic activity by the extracellular matrix. Biol Cell 1998;90:381–90. [19] Yamaguchi Y, Mann DM, Ruoslathi E. Negative regulation of the transforming growth factor-ß by the proteoglycan decorin. Nature 1990;346:281–4. [20] Zhou Z, Wang J, Cao R, Morita H, Soininen R, Chan KM, et al. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate deficient mice. Cancer Res 2004;64:4699–702. [21] Merrilees MJ, Lemire JM, Fisher JW, Kinsella MG, Brana KR, Clowees AW, et al. Retrovirally-mediated overexpression of versican V3 by arterial smooth muscle cell induces tropoelastin synthesis and elastic fiber formation in vitro and in neo-intima after vascular injury. Circ Res 2002;90:481–7. [22] Cattaruzza S, Perris R. Proteoglycan control of cell movement during wound healing and cancer spreading. Matrix Biol 2005;24:400–17. [23] Hattori N, Carinno DA, Lauer ME, Vascinji A, Wylie JD, Nelson CM, et al. Pericellular versican regulates the fibroblast-myofibroblast transition: a role for ADAMTS5 protease-mediated proteolysis. J Biol Chem 2007;39:505–28. [24] Elenius K, Vainio S, Laoto M, Salmivirta M, Thesleff I, Jalkanen M. Induced expression of syndecan in healing wounds. J Cell Biol 1991;114:585–95. [25] Stepp MA, Gibson HE, Gala PH, Iglesia DD, Pajookesh-Ganji A, Pal-Gosh S, et al. Defects in keratinocyte activation during wound healing in the syndecan-1deficient mice. J Cell Sci 2002;115:4517–31. [26] Echtermeyer F, Streit M, Wilcox-Adelman S, Saoncella S, Denhez F, Detmar M, et al. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest 2001;107:R9–14. [27] Lin F, Ren XD, Doris G, Clark RA. Three-dimensional migration of human adult dermal fibroblasts from collagen lattices into fibrin/fibronectin gels requires syndecan -4 proteoglycan. J Invest Dermatol 2005;124:906–13.
[28] Murphy-Ullrich JE, Poczatek M. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev 2000;11: 59–69. [29] Kanayama M, Kurotaki D, Asano T, Matsui Y, Nakayama Y, Saito Y, et al. Alpha-9 integrin and its ligands contitute critical joint microenvironments for development of auto-immune arthritis. J Immunol 2009;182: 8015–25. [30] Midwood KS, Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal 2009;3:287–310. [31] Rodrigues M, Yates CC, Nuschke A, Griffith L, Wells A. The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL. Tissue Eng Part A 2013;19:1972–83. [32] Lenselink EA. Role of fibronectin in normal wound healing. Int Wound J 2013. doi:10.1111/iwj.12109 [E-pub ahead of print]. [33] Maquart FX, Simeon A, Pasco S, Monboisse JC. Regulation of cell activity by the extracellular matrix: the concept of matrikines. J Soc Biol 1999;193: 423–8. [34] Mirastschijski U, Hasksma CJ, Tomasek JJ, Agren MS. Matrix metalloproteinase inhibitor GM6001 attenuates keratinocyte migration, contraction and myofibroblast formation in skin wounds. Exp Cell Res 2004;229:465–75. [35] Carmeliet P, Moons L, Lijnen R, Janssens S, Lupu F, Collen D, et al. Inhibitory role of plasminogen activator inhibitor in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation 1997;96:3184–91. [36] Maquart FX, Cornillet-Stoupy J, Randoux A, Borel JP. Inhibition of fibroblastic cell division by a fraction of structural glycoproteins extracted from rabbit dermis. Biochem Biophys Res Commun 1984;125:509–15. [37] Laskin DL, Kimura T, Sakakibara S, Riley DJ, Berg RA. Chemotactic activity of collagen-like polypeptides for human peripheral blood neutrophils. J Leukoc Biol 1986;39:255–66. [38] Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett 1988;238:343–6. [39] Freedman JH, Pickart L, Weinstein B, Mims WB, Peisach J. Structure of the Glycyl-L. -Histidyl-L-Lysine-copper (II) complex in solution. Biochemistry 1982;21:4540–4. [40] Sime´on A, Wegrowski Y, Bontemps Y, Maquart FX. Expression of glycosaminoglycans and small proteoglycans in wounds. Modulation by the tripeptidecopper complex Glycyl-L-Histidyl-L-Lysine-Cu2+. J Invest Dermatol 2000;115:962–8. [41] Maquart FX, Bellon G, Chaqour B, Wegrowski Y, Patt LM, Trachy RE, et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. J Clin Invest 1993;92:2368–76. [42] Choi HR, Kang YA, Ryoo SJ, Skin JW, Na JI, Huh CH, et al. Stem cell recovering effect of copper-free GHK in skin. J Pept Sci 2012;18:685–90. [43] Katayama K, Armendariz-Borunda J, Rhagow R, Kang AH, Seyer JM. A pentapeptide from type I collagen promotes extracellular matrix production. J Biol Chem 1993;268:9941–4. [44] Farwick M, Grether-Beck, Marini A, Maczkiewitz U, Lange J, Ko¨hler T, et al. Bioactive tetrapeptide GEKG boosts extracellular matrix formation: in vitro and in vivo molecular and clinical proof. Exp Dermatol 2011;20: 600–13. [45] Tsai WC, Hsu CC, Chung CY, Lin MS, Li SL, et al. The pentapeptide KTTKS promoting the expressions of type I collagen and transforming growth factorß of tendon cells. J Orthop Res 2007;25:1629–34. [46] Duca L, Floquet N, Alix AJ, Haye B, Debelle L. Elastin as a matrikine. Crit Rev Oncol Hematol 2004;49:235–44. [47] Robert L, Poullain N. Studies on the structure of elastin and the mode of action of elastase I. New method of preparation of soluble derivatives of elastin. Bull Soc Chim Biol (Paris) 1963;45:1317–26. [48] Jacob MP, Fu¨lop T, Foris G, Robert L. Effect of elastin peptides on ion fluxes in mononuclear cells, fibroblasts, and smooth muscle cells. Proc Natl Acad Sci U S A 1987;84:995–9. [49] Antonicelli F, Bellon G, Lorimier S, Hornebeck W. Role of the elastin receptor complex (S-Gal/Cath-A/Neu-1) in skin repair and regeneration. Wound Rep Reg 2009;17:631–8. [50] Duca L, Blanchevoye C, Cantarelli B, Gonheim C, Dedieu S, Delacoux F, et al. The elastin receptor complex transduces signals through the catalytic activity of its Neu-1 submit. J Biol Chem 2007;282:12484–91. [51] Brassart B, Fuchs P, Huet E, Alix. AJ, Wallach J, Tamburso AM, et al. Conformational dependence of collagenase (matrix metalloproteinase-1) up-regulation by elastin peptides in cultured fibroblasts. J Biol Chem 2001;276:5222–7. [52] Kariya Y, Miyazaki K. The basement membrane protein laminin-5 acts as a soluble cell mobility factor. Exp cell Res 2004;297:508–20. [53] Shang M, Koshikawa M, Schenk S, Quaranta V. The LG3 module of laminin-5 harbors a binding site for integrin alpha3beta1 that promotes cell adhesion, spreading and migration. J Biol Chem 2001;276:33045–53. [54] Swindle CS, Tran KT, Johnson TD, Banerjee P, Mayes AM, Griffith L, et al. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF-receptor. J Cell Biol 2001;154:459–68. [55] Adams E, Smith EL. Peptidases of erythrocytes. II. Isolation and properties of prolidase. J Biol Chem 1952;198:671–82. [56] Surazynski A, Donald SP, Cooper SK, Whyteside MA, Salnikox E, Lin Y, et al. Extracellular matrix and HIF-1 signaling: the role of prolidase. Int J Cancer 2008;122:1435–40.
Please cite this article in press as: Maquart FX, Monboisse JC. Extracellular matrix and wound healing. Pathol Biol (Paris) (2014), http:// dx.doi.org/10.1016/j.patbio.2014.02.007
G Model
PATBIO-3107; No. of Pages 5 F.X. Maquart, J.C. Monboisse / Pathologie Biologie xxx (2014) xxx–xxx [57] Ahluwalia A, Tarnowsky AS. Critical role of hypoxia sensor- HIF-1a in VEGF gene activation. Implications for angiogenesis and tissue injury healing. Curr Med Chem 2012;19:90–7. [58] Botusan IR, Sunkary VG, Savu O, Catrina AI, Gru¨nler J, Lindberg S, et al. Stabilization of HIF-1a is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci U S A 2008;19426–31. [59] Watt FM. Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J 2002;21:3919–26. [60] Grose R, Hutter C, Bloch W, Thorey I, Watt FM, Fa¨ssler R, et al. A crucial role of ß1-integrin for keratinocyte migration in vitro and during cutaneous wound repair. Development 2002;129:2303–15.
5
[61] Reynolds LE, Conti FJ, Silva R, Robinson SD, Iyer V, et al. A3ß1 integrincontrolled Smad 7 regulates reepithelialization during wound healing in mice. J Clin Invest 2008;118:965–74. [62] Senger DR, Claffey KP, Benes JE, Peruzzi CA, Sergiou AP, Detmar M. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci U S A 1997;94: 13612–7. [63] Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin alphavbeta3 for angiogenesis. Science 1994;264:569–71.
Please cite this article in press as: Maquart FX, Monboisse JC. Extracellular matrix and wound healing. Pathol Biol (Paris) (2014), http:// dx.doi.org/10.1016/j.patbio.2014.02.007
PATBIO-3107; No. of Pages 5 Pathologie Biologie xxx (2014) xxx–xxx
Available online at
ScienceDirect www.sciencedirect.com
60th anniversary
Extracellular matrix and wound healing Matrice extracellulaire et cicatrisation F.X. Maquart a,*,b, J.C. Monboisse a,b a b
Laboratoire de biochimie et biologie mole´culaire, CNRS FRE 3481, faculte´ de me´decine, 51, rue Cognacq-Jay, CS 30018, 51095 Reims, France Laboratoire central de biochimie, CHU de Reims, rue Serge-Kochman, 51092 Reims, France
A R T I C L E I N F O
A B S T R A C T
Article history: Received 13 December 2013 Accepted 17 February 2014 Available online xxx
Extracellular matrix has been known for a long time as an architectural support for the tissues. Many recent data, however, have shown that extracellular matrix macromolecules (collagens, elastin, glycosaminoglycans, proteoglycans and connective tissue glycoproteins) are able to regulate many important cell functions, such as proliferation, migration, protein synthesis or degradation, apoptosis, etc., making them able to play an important role in the wound repair process. Not only the intact macromolecules but some of their specific domains, that we called ‘‘Matrikines’’, are also able to regulate many cell activities. In this article, we will summarize main findings showing the effects of extracellular matrix macromolecules and matrikines on connective tissue and epithelial cells, particularly in skin, and their potential implication in the wound healing process. These examples show that extracellular matrix macromolecules or some of their specific domains may play a major role in wound healing. Better knowledge of these interactions may suggest new therapeutic targets in wound healing defects. ß 2014 Elsevier Masson SAS. All rights reserved.
Keywords: Extracellular matrix Wound healing Collagen Elastin Glycosaminoglycans Proteoglycans Connective tissue glycoproteins Matrikines
R E´ S U M E´
Mots cle´s : Matrice extracellulaire Cicatrisation Collage`ne E´lastine Glycosaminoglycannes Prote´oglycannes Glycoprote´ines du tissu conjonctif Matrikines
La matrice extracellulaire est connue de longue date comme support architectural pour les tissus. De nombreux re´sultats re´cents indiquent, cependant, que les macromole´cules matricielles (collage`ne, e´lastine, glycosaminoglycannes, prote´oglycannes et glycoprote´ines du tissu conjonctif) sont capables de re´guler de nombreuses fonctions cellulaires telles que la prolife´ration, la migration, la synthe`se ou la de´gradation des prote´ines, l’apoptose, etc., les rendant capables de jouer un roˆle important dans le processus de cicatrisation. Non seulement les mole´cules intactes, mais aussi certains de leurs domaines spe´cifiques, que nous avons appele´s « Matrikines », sont capables de re´guler de nombreuses activite´s cellulaires. Dans cet article, nous re´sumerons les principales de´couvertes montrant les effets des macromole´cules matricielles et des matrikines sur les cellules des tissus conjonctifs et les cellules e´pithe´liales, en particulier dans la peau, et leur implication potentielle dans le processus de cicatrisation. Ces exemples montrent que les macromole´cules de la matrice extracellulaire ou certains de leurs domaines spe´cifiques peuvent jouer un roˆle majeur dans la cicatrisation. Une meilleure connaissance de ces interactions peut sugge´rer de nouvelles cibles the´rapeutiques dans les de´ficits de cicatrisation. ß 2014 Elsevier Masson SAS. Tous droits re´serve´s.
1. Introduction Wound healing is a very complex process, associating cellular, molecular, biochemical and physiological events, which permit living organisms to repair accidental lesions. It necessitates the
* Corresponding author. E-mail address: [email protected] (F.X. Maquart).
coordinated intervention of many partners, among which blood cells, epithelial and connective tissue cells, inflammatory cells and many soluble factors, mainly coagulation factors, growth factors and cytokines. It is a dynamic and strongly regulated process implicating molecular, cellular and humoral components, which starts immediately after the initial lesion and will last until complete closure of the wound and restitution of a tissue as functional as possible. In the case of fetal wound, complete
http://dx.doi.org/10.1016/j.patbio.2014.02.007 0369-8114/ß 2014 Elsevier Masson SAS. All rights reserved.
Please cite this article in press as: Maquart FX, Monboisse JC. Extracellular matrix and wound healing. Pathol Biol (Paris) (2014), http:// dx.doi.org/10.1016/j.patbio.2014.02.007
G Model
PATBIO-3107; No. of Pages 5 2
F.X. Maquart, J.C. Monboisse / Pathologie Biologie xxx (2014) xxx–xxx
regeneration of the initial tissue may occur whereas in adults, the wound healing process conducts in most case to the formation of a collagenic scar [1]. Among the factors implicated in the control of the wound healing process, an important partner is the extracellular matrix. It is now well admitted that extracellular matrix is not only an architectural support for the tissues but also plays a major role in cell regulation. Presently, many data show that nearly all the extracellular matrix components are able to regulate cell behaviour. It is clear that the important extracellular matrix alterations that occur during wound healing make it a very important player in this process. This review will summarize main findings showing the effects of extracellular matrix macromolecules on the cells implicated in the wound healing process. A better understanding of the mechanisms involved in these cell-extracellular matrix interactions may suggest new targets for therapeutic strategies in the management of the wound healing defects. 2. The fibrin clot: a provisional matrix As pointed out by Richard Clark many years ago, the fibrin clot by itself constitutes a provisional extracellular matrix, composed of 95% fibrin and many other components, mainly fibronectin, SPARC/osteonectin, thrombospondin and vitronectin. These components may support cell migration necessary for wound healing, but also trigger the inflammation process. For instance, fibrin itself induces the secretion of IL-8 by endothelial cells and of TNFa, IL1ß, IL-6, MIP-1, MIP-2 and MCP-1 by mononuclear cells [2]. Fibrin is rapidly degraded by plasmin and neutrophil elastase. This degradation may induce the release of plasma growth factors trapped in the fibrin lattice, which might play an important role in the early events of wound healing. Fibrin also releases fibrin degradation products, most of which may stimulate the healing process. Fibrin degradation products can induce or amplify the inflammatory process. For instance, fibrinopeptides A and B are chemo-attractant for neutrophils, monocytes and macrophages; D-dimers induce secretion of IL-1ß and IL-6 by mononuclear cells; fragment E induces secretion of IL-1ß and IL-6 by mononuclear cells; fragment ß15-42 is chemo-attractant for neutrophils and fibroblasts (for review, see ref [3]). Fibrin degradation products were also shown to stimulate extracellular matrix deposition [4], fibroblast proliferation [5] and angiogenesis [6]. 3. Extracellular matrix macromolecules as modulators of cell functions in wound healing Extracellular matrix (ECM) is made of collagen and elastic fibers dispersed in a ground substance made of glycosaminoglycans, proteoglycans and connective tissue glycoproteins. Many data have shown that ECM is able to modulate wound repair, either directly by modulating important aspects of cell behaviour such as adhesion, migration, proliferation or survival, or indirectly by modulating extracellular protease secretion, activation and activity, or modulating growth factor activity or bioavailability. Actually, sequestration/release of growth factors by the ECM may prolongate growth factor action or modulate their activity on the cells implicated in the wound healing process. 3.1. Glycosaminoglycans Glycosaminoglycan chains are very important players in wound healing. The most important is hyaluronic acid, a non-sulfated glycosaminoglycan, very abundant in skin [7] where it forms long filaments (500 nm–10 mm) and provides to the tissue its visco-
elasticity and hydrophilicity. Hyaluronic acid, also called hyaluronan, interacts with cell surface receptors, mainly CD-44 and RHAMM (Receptor for HyaluronAn Mediated Mobility), but also Toll-like Receptors TLR-4 and TLR-2, and Inter Cellular Adhesion Molecule-1 (ICAM-1). The interaction of hyaluronan with its receptor induces very important events in the wound repair process: modulation of inflammation, chemotaxis, cell migration, collagen secretion and angiogenesis [8–10]. The abundance of hyaluronan in fetal skin is likely one of the factors which permits to the early gestation fetal skin wound to heal without scar formation [11]. Similarly, the over-expression of hyaluronan synthase-1 is able to induce regenerative wound repair in C57Bl/6 mice [12]. Many data demonstrated that the biological effects of hyaluronan are dependent of its molecular size. For instance, recent data from Ghazi et al. [13] showed that hyaluronan with a molecular weight comprised between 100–300 kDa was able to strongly stimulate keratinocyte migration whereas high molecular weight (1000– 1400 kDa) and low molecular weight (5–20 kDa) hyaluronan fragments had no effect. Earlier, David Raoudi et al. [14] demonstrated that native hyaluronan of high molecular weight (1.7 MDa) stimulated type III collagen production whereas low molecular weight hyaluronan fragments (12 disaccharide units) stimulated type I collagen production by human dermal fibroblasts. Low molecular weight fragments of hyaluronan (10 saccharide units) were also shown to stimulate angiogenesis in rat experimental wounds [15]. Sulfated glycosaminoglycans (chondroitin-sulfate, dermatansulfate, keratan-sulfate and heparan-sulfate) are linked to core proteins to form proteoglycans in normal tissues, especially in skin. Proteoglycan degradation by proteases in the wounds may, however, lead to the release of free glycosaminoglycan chains, which may modulate the wound healing process [16]. For instance, chondroitin-sulfate and dermatan-sulfate regulate growth factor activity and may stimulate nitric oxide production which, in turn, can modulate angiogenesis. Heparan-sulfate stimulates the release of IL-1, IL-6, PGE2 and TGF-ß, inhibits elastase and cathepsin-G activity, complexes chemokines, cytokines and growth factors. It is also well known to stabilize tetrameric complexes between FGF2 or other heparin-binding growth factors and their receptors, improving signal transduction [17]. Heparan sulfate chains may also bind VEGF and contribute to the modulation of its proangiogenic effects in the tissues [18]. 3.2. Proteoglycans Many proteoglycans are involved in the wound healing process. Main skin proteoglycans are small leucine-rich proteoglycans (SLRPs) family and versican, essentially present in the dermis, perlecan in the basement membrane, syndecans and glypicans on the cell surface. Decorin, the first known member of the SLRP family, was shown many years ago to negatively regulate TGF-ß [19]. Delayed wound healing was observed in perlecan-deficient mice, due to an impaired angiogenesis [20]. The V3 isoform of versican was shown to stimulate elastin production [21], to promote angiogenesis [22], and to induce transition of normal dermal fibroblasts to myofibroblasts [23]. Syndecans 1 and 4 are strongly expressed in wounds [24]. Their increased expression stimulate keratinocyte and endothelial cell migration whereas invalidation of the syndecan-4 chain delays wound closure and angiogenesis in mice [25,26]. Threedimensional migration of fibroblasts into fibrin is also decreased when syndecan-4 core protein synthesis is suppressed by anti-sense oligodeoxynucleotides [27]. 3.3. Connective tissue glycoproteins Connective tissue glycoproteins are a group of extracellular matrix macromolecules strongly involved in cell regulation and
Please cite this article in press as: Maquart FX, Monboisse JC. Extracellular matrix and wound healing. Pathol Biol (Paris) (2014), http:// dx.doi.org/10.1016/j.patbio.2014.02.007
G Model
PATBIO-3107; No. of Pages 5 F.X. Maquart, J.C. Monboisse / Pathologie Biologie xxx (2014) xxx–xxx
3
many of them may be involved in the wound healing process, either directly or indirectly. Thrombospondin-1, for instance, is well known for activating latent TGF-ß which [28] in turn, may activate fibroblasts to produce extracellular matrix. Tenascin-C, a matricellular protein transiently expressed during wound healing, was shown to stimulate macrophage and fibroblast activation [29]. It is also a potent stimulator of angiogenesis [30] and is able to protect multipotential mesenchymal stem cells from death cytokines [31]. Fibronectin also plays a crucial role in wound healing by promoting keratinocyte and fibroblast migration, wound contraction, and stabilization of the newly synthetized collagen matrix [32].
[49]. Elastokines interact with their target cells through a specific receptor complex composed of a spliced variant of ß-galactosidase (S-Gal) associated at the cell plasma membrane with neuraminidase-1 (Neu-1) and to cathepsin-A (Cath-A) [50], which binds the consensus sequence GXXPG, a peptide sequence with a type VIII ßturn conformation frequently found in elastin [51]. Laminin 3.3.2 (laminin-5) isoform present in the dermoepidermal junction also contains some domains, especially the LG3 domain of the a3 chain, which stimulate keratinocyte migration and proliferation [52,53]. The many EGF-like domains contained in the tenascin-C amino-acid sequence may also be released by proteases and interact with EGF receptor to stimulate fibroblast proliferation and migration [54].
4. Matrikines in wound healing
5. Small collagen-derived peptides and hypoxia in wound healing
Matrikines are specific domains of extracellular matrix macromolecules, released by partial proteolysis, which are able to modulate many cell activities [33]. Many published data indicate that they may play a major role in the control of wound repair. Matrikines may be produced during proteolytic degradation of extracellular matrix, a process necessary for wound healing. For instance, it was demonstrated that wound healing is severely affected in collagenase-deficient and in plasminogen/plasmindeficient mice [34,35]. The capacity of extracellular matrix macromolecules to exert biological activities on connective tissue cells was demonstrated that a fragment of connective tissue glycoproteins extracted from rabbit dermis was able to inhibit fibroblast proliferation [36]. On the other hand, Laskin et al. [37] demonstrated that collagenderived peptides containing 3 or 5 repeats of the Pro-Hyp-Gly tripeptide were able to exert chemotactic effects on polymorphonuclear neutrophils. One of the best characterized matrikines involved in wound repair is the tripeptide glycyl-histidyl-lysine (GHK) present in many extracellular matrix proteins such as the collagen a2(I), a2(V) and a2(IX) chains, the SPARC glycoprotein, thrombospondin-1, and fibrin a-chain [38]. The peptide may be released from the extracellular matrix proteins by proteases to exert biological effects. It is present in biological fluids under the form of a free or complexed with Cu2+ ions tripeptide [39]. Many data from our laboratory and others demonstrated that GHK has many biological effects in wound healing, such as stimulation of collagen, glycosaminoglycan and proteoglycan synthesis [40] and acceleration of wound healing in vivo [41]. Interestingly, recent data by Choi et al. [42] showed a stem cell recovering effect of copper-free GHK in skin, suggesting a modulating effect of this peptide on stem cell renewal. GHK and GHK-Cu complexes are now found in a lot of cosmetic products for skin repair. They are not, however, the only collagen-derived matrikine since two others, KTTKS (lysylthreonyl-threonyl-lysyl-serine), a penta-peptide derived from the carboxyl-terminal propeptide of type I collagen [43], and GEKG (glycyl-glutamyl-lysyl-glycine), a tetrapeptide derived from the type I collagen triple helical domain [44], were shown to stimulate extracellular matrix macromolecule production. Part of these effects are mediated by an up-regulation of TGFß [45]. Elastin degradation is also an important source of matrikines in pathological tissues. A biological activity of elastin-derived peptides, also called ‘‘elastokines’’ [46], was first demonstrated for kappa-elastin, a mixture of elastin fragments obtained by alkaline hydrolysis of elastic fibers [47], which was shown to modulate ion fluxes in mononuclear cells [48]. Elastokines are able to stimulate many events in the wound healing process: monocytes and polymorphonuclear neutrophil activation, leukocyte migration, chemotaxis, keratinocyte migration, fibroblast proliferation, vasodilatation, angiogenesis, and matrix remodeling
Matrikines are not the only peptides derived from extracellular matrix degradation. Actually, a large amount of proline and hydroxyproline-containing peptides are also released. Among them, Gly-Pro and Gly-Hyp dipeptides stimulate activity of prolidase (EC3.4.13.9), an enzyme which specifically releases proline and hydroxyproline from iminodipeptides [55]. Previous studies of Surazynski et al. [56] demonstrated that overexpression of prolidase resulted in increased hypoxia inducible factor-1a (HIF-1a). This effect was due both to an activation of the hypoxia response element (HRE) by prolidase, resulting in an increased transcription of the HIF-1a gene, and to an inhibition of HIF-1a degradation. Increased levels and increased stability of HIF-1a are responsible for VEGF gene activation which, in turn, activates angiogenesis and improves wound healing [57,58]. 6. The role of integrins in wound healing Integrins are very important partners in wound healing. They mediate attachment of cells to the extracellular matrix. They are also involved in the regulation of cell behaviour and play a major role in cell-extracellular matrix interactions [59]. In the case of wound healing, it was shown that b1-integrin is necessary for keratinocyte migration in vivo and in experimental wounds [60]. Similarly, it was demonstrated that the a3 subunit of a3b1 integrin was able to regulate reepithelialisation during wound healing through SMAD-7 activation [61]. Integrins are also involved in neo-angiogenesis, a very important process in wound healing. Blocking a1 and a2 integrins by specific antibodies suppressed the stimulation of neo-capillary formation by VEGF in dermal microvascular endothelial cells [62]. Similarly, blocking avb3 integrin expression in wound granulation tissue suppressed neo-angiogenesis induced by FGF-2 and TNF-a [63]. 7. Conclusion Intact or partially degraded extracellular matrix macromolecules may play a major role on the activity of the cells implicated in the wound healing process. They may act either directly by interacting with specific receptors of the cell surface membrane such as integrins, CD-44, the elastin receptor complex or others, or indirectly by modulating the activity, activation or bio-availability of many cytokines and growth factors. Every cell type involved in wound healing, inflammatory cells, keratinocytes, fibroblasts, endothelial cells or pluripotent stem cells are concerned by these interactions with extracellular matrix macromolecules or their fragments. Such interactions may constitute new target for the wound healing defects.
Please cite this article in press as: Maquart FX, Monboisse JC. Extracellular matrix and wound healing. Pathol Biol (Paris) (2014), http:// dx.doi.org/10.1016/j.patbio.2014.02.007
G Model
PATBIO-3107; No. of Pages 5 F.X. Maquart, J.C. Monboisse / Pathologie Biologie xxx (2014) xxx–xxx
4
Acknowledgements Author’s works are supported by the university of ReimsChampagne-Ardenne, CNRS, region Champagne-Ardenne, FEDER and the Ligue nationale contre le cancer. Mrs Pascale Hennequin and Sandrine E´tienne are greatly acknowledged for careful typing of the manuscript. References [1] Reinkes JM, Sorg H. Wound repair and regeneration. Eur Surg Res 2012;49: 35–43. [2] Clark RA, Lanigan JM, Della Pelle P, Mansean E, Dvorak HF, Colvin RB. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 1982;9:269–76. [3] Jennewein C, Tran N, Paulus P, Ellinghans P, Eble JA, Zacharowski K. Novel aspects of fibrin(ogen) fragments during inflammation. Mol Med 2011;17: 568–73. [4] Ahmann KA, Weinbaum JS, Johnson SL, Tranquillo RT. Fibrin degradation products enhance vascular smooth muscle cell proliferation and matrix deposition in fibrin-based tissue constructs fabricated in vitro. Tissue Engin Part A 2010;16:3261–70. [5] Gray AJ, Bishop JE, Reeves JT, Mecham RP, Laurent GJ. Partially degraded fibrin(ogen) stimulates fibroblast proliferation in vitro. Am J Resp Cell Mol Biol 1995;12:684–90. [6] Dvorak HF, Harvey VS, Estrella P, Brown LF, Mc Donagh J, Dvorak AM. Fibrincontaining gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 1987;57:673–86. [7] Manuskiatti W, Maibach HI. Hyaluronic acid and skin: wound healing and aging. Int J Dermatol 1996;35:539–44. [8] Frenkel JS. The role of hyaluronan in wound healing. Int Wound J 2012 [doc:10.1111/j 1742-481X.2012.01057.x]. [9] Chen WYJ, Abatangelo G. Functions of hyaluronan in wound repair. Wound Rep Reg 1999;7:79–89. [10] Prodicimi M, Bevilacqua C. Exogenous hyaluronic acid and wound healing: an up-dated vision. Panminerva Med 2012;54:129–35. [11] Lo DD, Zimmerman AS, Nauta A, Longaker MT, Lorenz HP. Scarless fetal skin wound healing update. Birth Defects Res C Embryo Today 2012;96:237–47. [12] Caskey RC, Allukian M, Lind RC, Herdrich BJ, Xu J, Radu A, et al. Lentiviralmediated over expression of hyaluronan synthase-1 (HAS-1) decreases the cellular inflammatory response and results in regenerative wound repair. Cell Tissue Res 2013;351:117–25. [13] Ghazi K, Deng-Pichon U, Warnet JM, Rat P. Hyaluronan fragments improve wound healing on in vitro cutaneous model through P2X7 purinoreceptor basal activation: role of molecular weight. PLoS ONE 2012;7:e48351. [14] David-Raoudi M, Tranchepain F, Deschevrel B, Vincent JC, Bogdanowicz P, Boumediene K, et al. Differential effects of hyaluronan and its fragments on fibroblasts: relation to wound healing. Wound Rep Reg 2008;16:274–87. [15] Gao F, Liu Y, Yang C, Wang Y, Shi X, Wei G. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis. Matrix Biol 2010;29:107–16. [16] Peplow PV. Glycosaminoglycan: a candidate to stimulate the repair of chronic wounds. Thromb Haemostas 2005;94:4–16. [17] Taylor KR, Gallo RL. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J 2006;20:9–22. [18] Ortega N, L’Faquihi FE, Ploue¨t J. Control of vascular endothelial growth factor angiogenic activity by the extracellular matrix. Biol Cell 1998;90:381–90. [19] Yamaguchi Y, Mann DM, Ruoslathi E. Negative regulation of the transforming growth factor-ß by the proteoglycan decorin. Nature 1990;346:281–4. [20] Zhou Z, Wang J, Cao R, Morita H, Soininen R, Chan KM, et al. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate deficient mice. Cancer Res 2004;64:4699–702. [21] Merrilees MJ, Lemire JM, Fisher JW, Kinsella MG, Brana KR, Clowees AW, et al. Retrovirally-mediated overexpression of versican V3 by arterial smooth muscle cell induces tropoelastin synthesis and elastic fiber formation in vitro and in neo-intima after vascular injury. Circ Res 2002;90:481–7. [22] Cattaruzza S, Perris R. Proteoglycan control of cell movement during wound healing and cancer spreading. Matrix Biol 2005;24:400–17. [23] Hattori N, Carinno DA, Lauer ME, Vascinji A, Wylie JD, Nelson CM, et al. Pericellular versican regulates the fibroblast-myofibroblast transition: a role for ADAMTS5 protease-mediated proteolysis. J Biol Chem 2007;39:505–28. [24] Elenius K, Vainio S, Laoto M, Salmivirta M, Thesleff I, Jalkanen M. Induced expression of syndecan in healing wounds. J Cell Biol 1991;114:585–95. [25] Stepp MA, Gibson HE, Gala PH, Iglesia DD, Pajookesh-Ganji A, Pal-Gosh S, et al. Defects in keratinocyte activation during wound healing in the syndecan-1deficient mice. J Cell Sci 2002;115:4517–31. [26] Echtermeyer F, Streit M, Wilcox-Adelman S, Saoncella S, Denhez F, Detmar M, et al. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest 2001;107:R9–14. [27] Lin F, Ren XD, Doris G, Clark RA. Three-dimensional migration of human adult dermal fibroblasts from collagen lattices into fibrin/fibronectin gels requires syndecan -4 proteoglycan. J Invest Dermatol 2005;124:906–13.
[28] Murphy-Ullrich JE, Poczatek M. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev 2000;11: 59–69. [29] Kanayama M, Kurotaki D, Asano T, Matsui Y, Nakayama Y, Saito Y, et al. Alpha-9 integrin and its ligands contitute critical joint microenvironments for development of auto-immune arthritis. J Immunol 2009;182: 8015–25. [30] Midwood KS, Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal 2009;3:287–310. [31] Rodrigues M, Yates CC, Nuschke A, Griffith L, Wells A. The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL. Tissue Eng Part A 2013;19:1972–83. [32] Lenselink EA. Role of fibronectin in normal wound healing. Int Wound J 2013. doi:10.1111/iwj.12109 [E-pub ahead of print]. [33] Maquart FX, Simeon A, Pasco S, Monboisse JC. Regulation of cell activity by the extracellular matrix: the concept of matrikines. J Soc Biol 1999;193: 423–8. [34] Mirastschijski U, Hasksma CJ, Tomasek JJ, Agren MS. Matrix metalloproteinase inhibitor GM6001 attenuates keratinocyte migration, contraction and myofibroblast formation in skin wounds. Exp Cell Res 2004;229:465–75. [35] Carmeliet P, Moons L, Lijnen R, Janssens S, Lupu F, Collen D, et al. Inhibitory role of plasminogen activator inhibitor in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation 1997;96:3184–91. [36] Maquart FX, Cornillet-Stoupy J, Randoux A, Borel JP. Inhibition of fibroblastic cell division by a fraction of structural glycoproteins extracted from rabbit dermis. Biochem Biophys Res Commun 1984;125:509–15. [37] Laskin DL, Kimura T, Sakakibara S, Riley DJ, Berg RA. Chemotactic activity of collagen-like polypeptides for human peripheral blood neutrophils. J Leukoc Biol 1986;39:255–66. [38] Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett 1988;238:343–6. [39] Freedman JH, Pickart L, Weinstein B, Mims WB, Peisach J. Structure of the Glycyl-L. -Histidyl-L-Lysine-copper (II) complex in solution. Biochemistry 1982;21:4540–4. [40] Sime´on A, Wegrowski Y, Bontemps Y, Maquart FX. Expression of glycosaminoglycans and small proteoglycans in wounds. Modulation by the tripeptidecopper complex Glycyl-L-Histidyl-L-Lysine-Cu2+. J Invest Dermatol 2000;115:962–8. [41] Maquart FX, Bellon G, Chaqour B, Wegrowski Y, Patt LM, Trachy RE, et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. J Clin Invest 1993;92:2368–76. [42] Choi HR, Kang YA, Ryoo SJ, Skin JW, Na JI, Huh CH, et al. Stem cell recovering effect of copper-free GHK in skin. J Pept Sci 2012;18:685–90. [43] Katayama K, Armendariz-Borunda J, Rhagow R, Kang AH, Seyer JM. A pentapeptide from type I collagen promotes extracellular matrix production. J Biol Chem 1993;268:9941–4. [44] Farwick M, Grether-Beck, Marini A, Maczkiewitz U, Lange J, Ko¨hler T, et al. Bioactive tetrapeptide GEKG boosts extracellular matrix formation: in vitro and in vivo molecular and clinical proof. Exp Dermatol 2011;20: 600–13. [45] Tsai WC, Hsu CC, Chung CY, Lin MS, Li SL, et al. The pentapeptide KTTKS promoting the expressions of type I collagen and transforming growth factorß of tendon cells. J Orthop Res 2007;25:1629–34. [46] Duca L, Floquet N, Alix AJ, Haye B, Debelle L. Elastin as a matrikine. Crit Rev Oncol Hematol 2004;49:235–44. [47] Robert L, Poullain N. Studies on the structure of elastin and the mode of action of elastase I. New method of preparation of soluble derivatives of elastin. Bull Soc Chim Biol (Paris) 1963;45:1317–26. [48] Jacob MP, Fu¨lop T, Foris G, Robert L. Effect of elastin peptides on ion fluxes in mononuclear cells, fibroblasts, and smooth muscle cells. Proc Natl Acad Sci U S A 1987;84:995–9. [49] Antonicelli F, Bellon G, Lorimier S, Hornebeck W. Role of the elastin receptor complex (S-Gal/Cath-A/Neu-1) in skin repair and regeneration. Wound Rep Reg 2009;17:631–8. [50] Duca L, Blanchevoye C, Cantarelli B, Gonheim C, Dedieu S, Delacoux F, et al. The elastin receptor complex transduces signals through the catalytic activity of its Neu-1 submit. J Biol Chem 2007;282:12484–91. [51] Brassart B, Fuchs P, Huet E, Alix. AJ, Wallach J, Tamburso AM, et al. Conformational dependence of collagenase (matrix metalloproteinase-1) up-regulation by elastin peptides in cultured fibroblasts. J Biol Chem 2001;276:5222–7. [52] Kariya Y, Miyazaki K. The basement membrane protein laminin-5 acts as a soluble cell mobility factor. Exp cell Res 2004;297:508–20. [53] Shang M, Koshikawa M, Schenk S, Quaranta V. The LG3 module of laminin-5 harbors a binding site for integrin alpha3beta1 that promotes cell adhesion, spreading and migration. J Biol Chem 2001;276:33045–53. [54] Swindle CS, Tran KT, Johnson TD, Banerjee P, Mayes AM, Griffith L, et al. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF-receptor. J Cell Biol 2001;154:459–68. [55] Adams E, Smith EL. Peptidases of erythrocytes. II. Isolation and properties of prolidase. J Biol Chem 1952;198:671–82. [56] Surazynski A, Donald SP, Cooper SK, Whyteside MA, Salnikox E, Lin Y, et al. Extracellular matrix and HIF-1 signaling: the role of prolidase. Int J Cancer 2008;122:1435–40.
Please cite this article in press as: Maquart FX, Monboisse JC. Extracellular matrix and wound healing. Pathol Biol (Paris) (2014), http:// dx.doi.org/10.1016/j.patbio.2014.02.007
G Model
PATBIO-3107; No. of Pages 5 F.X. Maquart, J.C. Monboisse / Pathologie Biologie xxx (2014) xxx–xxx [57] Ahluwalia A, Tarnowsky AS. Critical role of hypoxia sensor- HIF-1a in VEGF gene activation. Implications for angiogenesis and tissue injury healing. Curr Med Chem 2012;19:90–7. [58] Botusan IR, Sunkary VG, Savu O, Catrina AI, Gru¨nler J, Lindberg S, et al. Stabilization of HIF-1a is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci U S A 2008;19426–31. [59] Watt FM. Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J 2002;21:3919–26. [60] Grose R, Hutter C, Bloch W, Thorey I, Watt FM, Fa¨ssler R, et al. A crucial role of ß1-integrin for keratinocyte migration in vitro and during cutaneous wound repair. Development 2002;129:2303–15.
5
[61] Reynolds LE, Conti FJ, Silva R, Robinson SD, Iyer V, et al. A3ß1 integrincontrolled Smad 7 regulates reepithelialization during wound healing in mice. J Clin Invest 2008;118:965–74. [62] Senger DR, Claffey KP, Benes JE, Peruzzi CA, Sergiou AP, Detmar M. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci U S A 1997;94: 13612–7. [63] Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin alphavbeta3 for angiogenesis. Science 1994;264:569–71.
Please cite this article in press as: Maquart FX, Monboisse JC. Extracellular matrix and wound healing. Pathol Biol (Paris) (2014), http:// dx.doi.org/10.1016/j.patbio.2014.02.007